Finance

Lists
1SXP:ETR
SCHOTT Pharma AG & Co KgaA
22,30 €
0,00%
(0,00) 1D
13 ნოე, 17:35:21 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1SXP...
Open
22,60 €
High
22,60 €
Low
22,20 €
Mkt. cap
3,40 მლრდ.
Avg. vol.
88,55 ათ.
Volume
56,75 ათ.
Dividend
0,81%
Quarterly dividend
0,05 €
Ex-dividend date
4 თებ. 2026
P/E ratio
24,44
52-wk high
26,20 €
52-wk low
12,62 €
EPS
0,91 €
Shares outstanding
150,61 მლნ.
No. of employees
5 ათ.
Open
22,60 €
High
22,60 €
Low
22,20 €
Mkt. cap
3,40 მლრდ.
Avg. vol.
88,55 ათ.
Volume
56,75 ათ.
Dividend
0,81%
Quarterly dividend
0,05 €
Ex-dividend date
4 თებ. 2026
P/E ratio
24,44
52-wk high
26,20 €
52-wk low
12,62 €
EPS
0,91 €
Shares outstanding
150,61 მლნ.
No. of employees
5 ათ.
News stories
From web sources and news partners
Profile
Schott Pharma is a provider of drug containment solutions and delivery systems for injectable drugs. Originally a division of glass manufacturer Schott AG, the company went public on the Frankfurt Stock Exchange in 2023. Headquartered in Mainz, Germany, the company operates in 14 countries. Wikipedia
About SCHOTT Pharma AG & Co KgaA
CEO-
Employees5 ათ.
Founded1 აგვ. 2022
Headquarters-
SectorHealth Care
Industry-
Websiteschott-pharma.com
Last report
12 აგვ. 2026
Fiscal period
Q3 2026
0,26 € / 0,26 €
-1,81%miss
Revenue / Est. (EUR)
281,76 მლნ. / 272,46 მლნ.
+3,41%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
247,58 მლნ.
240,19 მლნ.
247,88 მლნ.
281,76 მლნ.
Cost of goods sold
171,50 მლნ.
160,44 მლნ.
172,78 მლნ.
195,38 მლნ.
Cost of revenue
171,50 მლნ.
160,44 მლნ.
172,78 მლნ.
195,38 მლნ.
Research and development expenses
6,36 მლნ.
7,34 მლნ.
6,05 მლნ.
6,34 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
32,89 მლნ.
33,73 მლნ.
32,51 მლნ.
35,30 მლნ.
Operating expense
35,95 მლნ.
40,70 მლნ.
35,55 მლნ.
37,48 მლნ.
Total operating expenses
207,45 მლნ.
201,14 მლნ.
208,33 მლნ.
232,86 მლნ.
Operating income
40,14 მლნ.
39,05 მლნ.
39,55 მლნ.
48,90 მლნ.
Other non operating income
-61,00 ათ.
-79,00 ათ.
-212,00 ათ.
-116,00 ათ.
EBT including unusual items
41,76 მლნ.
42,04 მლნ.
40,31 მლნ.
51,23 მლნ.
EBT excluding unusual items
41,02 მლნ.
42,04 მლნ.
40,31 მლნ.
51,23 მლნ.
Income tax expense
8,09 მლნ.
8,76 მლნ.
9,17 მლნ.
12,25 მლნ.
Effective tax rate
19,37%
20,84%
22,76%
23,91%
Other operating expenses
-3,30 მლნ.
-366,00 ათ.
-3,01 მლნ.
-4,16 მლნ.
Net income
33,56 მლნ.
33,18 მლნ.
31,01 მლნ.
38,83 მლნ.
Net profit margin
13,55%
13,81%
12,51%
13,78%
Earnings per share
0,22
0,22
0,21
0,26
Interest and investment income
2,02 მლნ.
2,33 მლნ.
1,84 მლნ.
1,96 მლნ.
Interest expense
-4,71 მლნ.
-4,00 მლნ.
-4,01 მლნ.
-3,87 მლნ.
Net interest expenses
-2,69 მლნ.
-1,67 მლნ.
-2,16 მლნ.
-1,91 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
56,70 მლნ.
60,46 მლნ.
61,41 მლნ.
71,14 მლნ.
Gain or loss from assets sale
-88,00 ათ.
-48,00 ათ.
-72,00 ათ.
48,00 ათ.
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები